NeuMoDx Plans Saliva Sample Extension to EUA for Its SARS-CoV-2 Test
NeuMoDx is seeking to expand the workflow of its covid-19 test to include testing of saliva specimens collected in the NeuMoDx saliva collection device.
Read MorePosted by Laurie Bonner | May 14, 2020 | Covid 19, Uncategorized |
NeuMoDx is seeking to expand the workflow of its covid-19 test to include testing of saliva specimens collected in the NeuMoDx saliva collection device.
Read MorePosted by Laurie Bonner | May 13, 2020 | Covid 19, Uncategorized |
Using the company’s namesake method, the covid-19 kit works by programming a CRISPR molecule to detect the genetic signature of the SARS-CoV-2 virus.
Read MorePosted by Laurie Bonner | May 8, 2020 | Covid 19 |
The company’s latest covid-19 products include a protein-coated RNA process control, and an in vitro diagnostics control with pooled gene targets.
Read MorePosted by Laurie Bonner | May 7, 2020 | Covid 19 |
In the United States, the digital pathology software will support the need for remote pathology brought about by the covid-19 pandemic.
Read MorePosted by | May 6, 2020 | Covid 19, Digital Pathology, Emerging & Zoonotic Diseases, Infectious Diseases, Mounting Systems & Substrates |
Increased availability of such devices may help to facilitate continuity of patient care by preventing disruptions to critical pathology services.
Read More